Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niki B Istwan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Obstetrics and Gynecology|October 28, 2004
The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapyJohn P Elliott, Niki B Istwan, Debbie Rhea, et al.
American Journal of Perinatology|May 12, 2012
Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011Baha M Sibai, Niki B Istwan, Beverly Palmer, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|May 14, 2004
Clinical and economic outcomes of preterm labor management: inpatient vs outpatientSteven Ambrose, Debbie J Rhea, Niki B Istwan, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 22, 2004
Indicated and non-indicated preterm delivery in twin gestations: impact on neonatal outcome and costJohn P Elliott, Niki B Istwan, Ann Collins, et al.
Managed Care (Langhorne, Pa.)|August 2, 2003
Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm laborFung Lam, Niki B Istwan, Debbie Jacques, et al.
American Journal of Perinatology|December 17, 2009
The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth preventionSaju Joy, Debbie J Rhea, Niki B Istwan, et al.
Disease Management : DM|August 9, 2006
Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditionsJohn R Barton, Niki B Istwan, Debbie Rhea, et al.
Managed Care (Langhorne, Pa.)|November 6, 2002
Is 34 weeks an acceptable goal for a complicated singleton pregnancy?J Stephen Jones, Niki B Istwan, Debbie Jacques, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 22, 2004
The impact of hydramnios on pregnancy outcome in twin gestationsAyfer Orhan, Richard B Kurzel, Niki B Istwan, et al.
The Journal of Reproductive Medicine|March 24, 2009
Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillanceCharles Rittenberg, Roger B Newman, Niki B Istwan, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Obstetrics and Gynecology|October 28, 2004
The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapyJohn P Elliott, Niki B Istwan, Debbie Rhea, et al.
American Journal of Perinatology|May 12, 2012
Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011Baha M Sibai, Niki B Istwan, Beverly Palmer, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|May 14, 2004
Clinical and economic outcomes of preterm labor management: inpatient vs outpatientSteven Ambrose, Debbie J Rhea, Niki B Istwan, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 22, 2004
Indicated and non-indicated preterm delivery in twin gestations: impact on neonatal outcome and costJohn P Elliott, Niki B Istwan, Ann Collins, et al.
Managed Care (Langhorne, Pa.)|August 2, 2003
Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm laborFung Lam, Niki B Istwan, Debbie Jacques, et al.
American Journal of Perinatology|December 17, 2009
The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth preventionSaju Joy, Debbie J Rhea, Niki B Istwan, et al.
Disease Management : DM|August 9, 2006
Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditionsJohn R Barton, Niki B Istwan, Debbie Rhea, et al.
Managed Care (Langhorne, Pa.)|November 6, 2002
Is 34 weeks an acceptable goal for a complicated singleton pregnancy?J Stephen Jones, Niki B Istwan, Debbie Jacques, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 22, 2004
The impact of hydramnios on pregnancy outcome in twin gestationsAyfer Orhan, Richard B Kurzel, Niki B Istwan, et al.
The Journal of Reproductive Medicine|March 24, 2009
Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs. daily nursing surveillanceCharles Rittenberg, Roger B Newman, Niki B Istwan, et al.
Pageof 4